Please use this identifier to cite or link to this item:
https://doi.org/10.2337/db10-1198
Title: | Glycated hemoglobin and the risk of kidney disease and retinopathy in adults with and without diabetes | Authors: | Selvin, E. Ning, Y. Steffes, M.W. Bash, L.D. Klein, R. Wong, T.Y. Astor, B.C. Sharrett, A.R. Brancati, F.L. Coresh, J. |
Issue Date: | Jan-2011 | Citation: | Selvin, E., Ning, Y., Steffes, M.W., Bash, L.D., Klein, R., Wong, T.Y., Astor, B.C., Sharrett, A.R., Brancati, F.L., Coresh, J. (2011-01). Glycated hemoglobin and the risk of kidney disease and retinopathy in adults with and without diabetes. Diabetes 60 (1) : 298-305. ScholarBank@NUS Repository. https://doi.org/10.2337/db10-1198 | Abstract: | OBJECTIVE: Glycated hemoglobin was recently recommended for use as a diagnostic test for diabetes. We examined the association between 2010 American Diabetes Association diagnostic cut points for glycated hemoglobin and microvascular outcomes (chronic kidney disease, end-stage renal disease [ESRD], and retinopathy) and formally tested for the presence of risk thresholds in the relationships of glycated hemoglobin with these outcomes. RESEARCH DESIGN AND METHODS: Prospective cohort and cross-sectional analyses of 11,357 participants (773 with a history of diagnosed diabetes) from the Atherosclerosis Risk in Communities (ARIC) Study. RESULTS: During a median of 14 years of follow-up of individuals without diagnosed diabetes at baseline, clinical categories of glycated hemoglobin were associated with risk of chronic kidney disease, with adjusted hazard ratios (HRs) of 1.12 (0.94 -1.34) and 1.39 (1.04 -1.85) for glycated hemoglobin 5.7- 6.4% and | Source Title: | Diabetes | URI: | http://scholarbank.nus.edu.sg/handle/10635/109370 | ISSN: | 00121797 | DOI: | 10.2337/db10-1198 |
Appears in Collections: | Staff Publications |
Show full item record
Files in This Item:
There are no files associated with this item.
Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.